West Pharmaceutical Services (WST) Cash from Restructuring (2018 - 2026)

West Pharmaceutical Services' (WST) quarterly Cash from Restructuring came in at $900000.0 in Q1 2026, up 12.5% year-on-year from $800000.0 in Q1 2025, and up 12.5% quarter-over-quarter from $800000.0 in Q1 2025.

West Pharmaceutical Services (WST) Cash from Restructuring (2018 - 2026) Analysis & Trends

West Pharmaceutical Services has disclosed Cash from Restructuring across 4 years of filings, most recently posting $900000.0 for Q1 2026.

  • Cash from Restructuring for Q1 2026 came in at $900000.0, up 12.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (up 112.5% YoY), and the FY2025 annual result was $5.4 million, changed N/A from the prior year.
  • Cash from Restructuring came in at $900000.0 for Q1 2026 at West Pharmaceutical Services, up from $800000.0 in the prior quarter.
  • In the past five years, Cash from Restructuring ranged from a high of $900000.0 in Q1 2026 to a low of $800000.0 in Q1 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn
10 Aptargroup 7.72 Bn 7.52 Bn 351.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 900,000.00
Mar 31, 2025 800,000.00
Dec 31, 2019 700,000.00
Sep 30, 2019 1.20 Mn
Jun 30, 2019 100,000.00
Mar 31, 2019 300,000.00
Dec 31, 2018 1.40 Mn
Sep 30, 2018 400,000.00
Jun 30, 2018 300,000.00
Mar 31, 2018 100,000.00